Skip to Content

Tag: Food and Drug Administration

Specialty Providers

FDA report underscores need for qualified providers

March 3, 2010Theresa Flaherty, Managing Editor

WASHINGTON - A December Food and Drug Administration (FDA) advisory about the potential risks of negative pressure wound therapy (NPWT) underscores the importance of ensuring that the therapy is offered by qualified providers, say industry stakeholders. "The FDA's real objective is to be sure that providers and patients are aware that there are serious risks associated with NPWT," said Patricia Burns, senior director of clinical affairs for Smith & Nephew. "We are very committed to the appropriate...

Food and Drug Administration, Negative pressure wound therapy

Read Full Articlered right arrow icon